Krystal Biotech (KRYS) Inventory Average (2023 - 2026)
Krystal Biotech (KRYS) posted quarterly Inventory Average of $44.1 million for Q2 2026, up 44.63% year-over-year from $30.5 million in Q2 2025, and up 6.11% on a QoQ basis from $41.6 million in Q1 2026.
Krystal Biotech (KRYS) Inventory Average (2023 - 2026) Analysis & Trends
Krystal Biotech has reported Inventory Average for 4 years, with the latest figure at $44.1 million in Q2 2026.
- Inventory Average for Q2 2026 came in at $44.1 million, up 44.63% year-over-year; the trailing twelve-month figure through Jun 2026 was $44.1 million (up 44.63% YoY), and the FY2025 annual result was $33.5 million, up 99.99% from the prior year.
- Inventory Average grew to $44.1 million in Q2 2026, from $41.6 million in the prior quarter.
- Over five years, Inventory Average peaked at $44.1 million in Q2 2026 and troughed at $6.1 million in Q4 2023.
- A 4-year average of $25.7 million and a median of $28.2 million in 2025 frame the typical range for Inventory Average.
- The widest annual swing landed in 2024, when Inventory Average jumped 267.68%; it then soared 44.63% in 2026.
- A 4-year view of Inventory Average shows it stood at $6.1 million in 2023, then jumped by 267.68% to $22.5 million in 2024, then surged by 73.23% to $39.1 million in 2025, then grew by 12.92% to $44.1 million in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $44.1 million in Q2 2026, $41.6 million in Q1 2026, and $39.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Krystal Biotech | 9.83 Bn | 8.99 Bn | 112.79 Mn | 44.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.10 Mn |
| Mar 31, 2026 | 41.56 Mn |
| Dec 31, 2025 | 39.05 Mn |
| Sep 30, 2025 | 34.34 Mn |
| Jun 30, 2025 | 30.49 Mn |
| Mar 31, 2025 | 28.23 Mn |
| Dec 31, 2024 | 22.54 Mn |
| Sep 30, 2024 | 15.38 Mn |
| Jun 30, 2024 | 11.61 Mn |
| Mar 31, 2024 | 9.01 Mn |
| Dec 31, 2023 | 6.13 Mn |